Article
Smad4 Inactivation Promotes Malignancy and Drug Resistance of Colon Cancer
19 Jan 2011
Abstract excerpt
SMAD4 is localized to chromosome 18q21, a frequent site for loss of heterozygosity in advanced stage colon cancers. Although Smad4 is regarded as a signaling mediator of the TGFβ signaling pathway, its role as a major suppressor of colorectal cancer progression and the molecular events underlying this phenomenon remain elusive. Here, we describe the establishment and use of colon cancer cell line model systems to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
